Perspective · 8 Dec 2023
Conference abstractPublished 25 Sep 2014
Good practices on pharma distribution: A case study
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The existing GDP (Good Distribution Practices) guidelines set up general principles on distribution of medicinal products, but the reality of their implementation can often be nuanced. At the Global level, distribution faces additional challenges, more so in regions like Latin America, where going across national borders is anything but easy. The markets, however, are still there, demanding distribution to more than 200 million people. In this context, the choice of 3PL can play a crucial role in strengthening the global supply chain. A necessary condition for this achievement is the setting up of a real partnership that transcends the heretofore commonplace customer-supplier relationship. The most commonly used models of contracts with these operators will be presented. The benefits of the RDC (Regional Distribution Center) model may involve not just good distribution practices, but other issues that are often more important to pharmaceutical companies (inventory planning, lower lead times, financial and tax benefits, product customization, and so on). Uruguay, squeezed between two regional giants, Brazil and Argentina, has proven the best solution in negotiating these difficulties, a major reason why many global companies have chosen this small country as their Gateway to the region. Having the only free trade zone inside a South American airport represents an additional benefit. Several examples of multinational companies will show how these benefits apply to concrete cases
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 21 Oct 2013
Good distribution practices (cGDP) and related regulatory affairs at the Brazilian supply chain
Research article · 2011
“Quality Tools for Improving a System of documentation as the basis for Good Manufacturing Practices”. Practical Case
Article · 2011
andldquo;Quality Tools for Improving a System of documentation as the basis for Good Manufacturing Practicesandrdquo;. Practical Case
Commentary · 14 Feb 2024
Enhancing Healthcare Practice Analysis in Pharma Science
More from this journal
The newest in Journal of Developing Drugs.
Research article · 17 Jul 2026
Effects of a Food-Derived GLP-1 Formula on Endogenous GLP-1 Secretion and Appetite Responses: A Randomized Double-Blind Crossover Study
Commentary · 4 Feb 2026
Vaccine Development and Global Disease Prevention
Commentary · 4 Feb 2026
Transforming Drug Development Through Pharmaceutical Biotechnology
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Developing Drugs
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Bruno Guella”

